MOHW

Endonovo's SofPulse® Secures Taiwan FDA Approval

Retrieved on: 
Thursday, October 12, 2023
Partnership, Health, OTCQB, Hospital, Ministry of Health and Welfare (Taiwan), Food, NHI, Inflammation, Therapy, Ministry, Marketing, PEMF, Surgeon, MOHW, Attention, Patient, Medical device, Medical imaging, Pharmaceutical industry, Dentistry, Video game, Nursing

The SofPulse® TFDA approval marks the initial phase of Endonovo's expansion, through EverMed, into the largely untapped PEMF and surgical sectors in Taiwan.

Key Points: 
  • The SofPulse® TFDA approval marks the initial phase of Endonovo's expansion, through EverMed, into the largely untapped PEMF and surgical sectors in Taiwan.
  • Ira Weisberg, President of Endonovo's SofPulse® division, stated: "We are eager to collaborate with EverMed to expand SofPulse® use throughout Taiwan.
  • The TFDA is the regulatory arm of Taiwan’s MOHW and is considered the driving force behind healthcare improvement in Taiwan.
  • The establishment of an international distribution agreement in Taiwan, with EverMed helps establish Endonovo’s willingness to expand globally into new regions increasing brand awareness internationally.

‘Medical Korea 2023 Conference’ on Global Medical Industry Prospects to Kick off on March 23 at Coex

Retrieved on: 
Wednesday, March 22, 2023
Destinations, Travel, Other Health, Health, General Health, Pharmaceutical, Research, Hospitals, Science, Telemedicine, Virtual Medicine, Other Travel, Single-frequency network, Medicine, Exhibition, COVID-19, Bumrungrad International Hospital, MKA, Multimedia, Ministry, Ministry of Health and Welfare (South Korea), MOHW, Tourism, Therapy, Digital, Conference, Medical tourism, Pharmaceutical industry, Health care, Management, G2G, Coex

The Ministry of Health and Welfare (MOHW) and the Korea Health Industry Development Institute (KHIDI) will host Medical Korea 2023 - The 13th Global Healthcare & Medical Tourism Conference at Coex in Seoul from March 23 (Thu) to March 24 (Fri), 2023.

Key Points: 
  • The Ministry of Health and Welfare (MOHW) and the Korea Health Industry Development Institute (KHIDI) will host Medical Korea 2023 - The 13th Global Healthcare & Medical Tourism Conference at Coex in Seoul from March 23 (Thu) to March 24 (Fri), 2023.
  • View the full release here: https://www.businesswire.com/news/home/20230321005095/en/
    Medical Korea 2023 Conference, which celebrates its 13th this year, will be held as a large-scale offline event in three years after the outbreak of COVID-19, from March 23 to 24 at Coex in SEOUL.
  • Medical Korea 2023 is one of the largest global healthcare conferences in Korea with the aim of the globalization of the Korean healthcare industry.
  • More information on Medical Korea 2023: www.mkconf.org

SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines

Retrieved on: 
Tuesday, October 25, 2022
Lassa mammarenavirus, Bill, RNA transfection, Pandemic, Second, CEPI, GIA, Virus, CMV, Ministry of Health and Welfare (South Korea), JEV, Vaccine, Organization, Foundation, RSV, SK, RNA, MOHW, Equitable, Partnership, Technology, Infection, Epidemic, Company, Public health, Health, CEO, Ministry, Park Min-soo, Coalition, Control, COVID-19, USD, Policy, Pharmaceutical industry

USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil.

Key Points: 
  • USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil.
  • Under the agreement, SK bioscience will receive up to 140 million USD in R&D expenses from CEPI.
  • Earlier, SK bioscience had the partnership with the Bill & Melinda Gates Foundation in order to build the mRNA vaccine platform.
  • CEPI and SK bioscience are committed to enabling global equitable access to the vaccines they develop.